Key result
This review provides an update on the classification, pathophysiology, diagnosis, and treatment of pulmonary arterial hypertension, with a specific focus on its impact on women.
This review provides an update on the classification, pathophysiology, diagnosis, and treatment of pulmonary arterial hypertension, with a specific focus on its impact on women.
May guide sex-specific PAH considerations; leaves open need for dedicated prospective trials in women.
Pulmonary arterial hypertension (PAH) is characterized by pathological hemodynamic elevation in pulmonary artery pressure. Development of international registries over the last decade has raised awareness about the disease, leading to the development of new and improved therapies. Paradigm shifts such as these warrant review of existing literature regarding PAH, especially in females, as the disease continues to affect women more than males. The aim of this review is to provide an update on the classification, pathophysiology, diagnosis, and treatment of PAH while focusing specifically on its impact on women.
No takes yet. Share an insight, caveat, or question.
Memon et al. (2017) conducted a review in Pulmonary arterial hypertension. This review provides an update on the classification, pathophysiology, diagnosis, and treatment of pulmonary arterial hypertension, with a specific focus on its impact on women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: